advertisement

---

Batoosingh AL 1

Showing records 1 to 1 | Display all abstracts from Batoosingh AL

26206 Twelve-month, randomized, controlled trial of bimatoprost 0.01%, 0.0125%, and 0.03% in patients with glaucoma or ocular hypertension
Katz LJ; Cohen JS; Batoosingh AL; Felix C; Shu V; Schiffman RM
American Journal of Ophthalmology 2010; 149: 661-671

---